CLPT Stock Analysis: Buy, Sell, or Hold?
CLPT - ClearPoint Neuro, Inc. Common Stock
$18.76
1.70 (9.96%)
▲
5d:
+38.76%
30d:
+60.34%
90d:
+97.27%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When CLPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CLPT is 21.7% above its trading range ($15.41). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CLPT is 21.7% above its trading range ($15.41). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CLPT is currently trading at $18.76, which is considered extended relative to its 30-day fair value range of $11.31 to $15.41.
Technical Outlook: Technically, CLPT is showing sideways momentum. The price is approaching resistance at $18.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.0% recently.
Market Sentiment: CLPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.33 (+66.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLPT is showing sideways momentum. The price is approaching resistance at $18.94. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 10.0% recently.
Market Sentiment: CLPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.33 (+66.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.31 -
$15.41
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
CLPT is technically overbought (RSI 75). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+21.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.0%)
- BULLISH: Trading 66.1% below Wall St target ($28.33)
- WARNING: Recommendation downgraded due to 21.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$11.31 -
$15.41
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$12.82
Resistance Level
$18.94
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.15
Wall Street Target
$28.33
(+66.1%)
Revenue Growth (YoY)
42.9%
Profit Margin
-71.6%
Share & Embed Analysis
Last updated: June 23, 2026 3:35 PM ET
Data refreshes hourly during market hours. Next update: 4:35 PM
Data refreshes hourly during market hours. Next update: 4:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph Burnett
SELL
2943 shares
2026-01-26
Joseph Burnett
SELL
20000 shares
2026-01-09
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
Advanced CLPT Option Strategies
Professional options setups generated by AI based on today's CLPT price and gamma walls.
